Digest Network Come funziona
Network
/
SocietĂ 
Zy
Non verificato

Zymeworks Inc.

Di cosa scriviamo

Annunci EconomiciBiotecnologiaFinanzaMedicina Salute BenesserePubblico Esercizio/Vendita al dettaglio

47 comunicati stampa

Guarda tutti i comunicati
29/06/2026
Biotecnologia
Zymeworks to Acquire Theravance Biopharma, Inc.
Fonte
Zymeworks Inc.
Emittente
GLOBENEWSWIRE
1.00
0
14/06/2026
Biotecnologia
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
Fonte
Zymeworks Inc.
Emittente
GLOBENEWSWIRE
1.00
0
14/05/2026
Biotecnologia
Finanza
Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock
Fonte
Zymeworks Inc.
Emittente
GLOBENEWSWIRE
1.00
0
13/05/2026
Biotecnologia
Zymeworks Announces Participation in Upcoming Investor Conferences
Fonte
Zymeworks Inc.
Emittente
GLOBENEWSWIRE
1.00
0
21/04/2026
Biotecnologia
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026
Fonte
Zymeworks Inc.
Emittente
GLOBENEWSWIRE
1.00
0
17/04/2026
Biotecnologia
Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform
Fonte
Zymeworks Inc.
Emittente
GLOBENEWSWIRE
1.00
0
09/04/2026
Biotecnologia
Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth
Fonte
Zymeworks Inc.
Emittente
GLOBENEWSWIRE
1.00
0
01/04/2026
Biotecnologia
Zymeworks Appoints Kristin Stafford as Chief Financial Officer
Fonte
Zymeworks Inc.
Emittente
GLOBENEWSWIRE
1.00
0
30/03/2026
Biotecnologia
Annunci Economici
Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate
Fonte
Zymeworks Inc.
Emittente
GLOBENEWSWIRE
1.00
0
18/03/2026
Biotecnologia
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting
Fonte
Zymeworks Inc.
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
CompatibilitĂ 
0